A SIMPLE KEY FOR MBL77 UNVEILED

Not all patients with CLL call for therapy. Despite all new advances, the iwCLL even now endorses watchful observation for patients with asymptomatic condition.86 This advice is predicated on at the least two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Both o